• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Tool identifies diabetes patients at risk for severe hypoglycemia

August 21, 2017 By Sarah Faulkner

Kaiser PermanenteResearchers have developed a tool used to identify diabetes patients who are at-risk for being admitted to the hospital due to severe hypoglycemia, according to a study published today in JAMA Internal Medicine.

“Sometimes a person with diabetes is unaware that their blood sugar is dropping and can progress quickly into severe hypoglycemia, which has been associated with falls, automobile accidents, heart attacks, coma, and even death,” Andrew Karter, senior research scientist at Kaiser Permanente, said in prepared remarks. “Hypoglycemia is often preventable with the proper clinical attention, and we believe this tool will help focus that attention on the patients who most need it.”

Hypoglycemia is one of the most common adverse events in patients with Type II diabetes, and elderly patients or those who have a long history of diabetes are especially susceptible.

The research team first identified 156 hypoglycemia risk factors and collected data from more than 200,000 Type II diabetes patients. The scientists used machine-learning to develop a model that can predict a patient’s 12-month risk of hospitalization due to severe low blood sugar.

The analytical model was based on six variables – the number of prior hypoglycemia-related ED visits, insulin use, use of a common oral diabetes medicine, severe or end-stage kidney disease, number of ED visits for any reason in the last year and a patient’s age.

According to the model, the team devised a tool that categorizes patients into high (>5%), intermediate (1-5%) or low (<1%) 12-month risk of hospitalization due to hypoglycemia. The tool was validated using data from 1.3 milliom members of the U.S. Veterans Health Administration and thousands of Kaiser Permanente members in Washington.

The FDA helped to fund the development of this tool under its Safe Use Initiative.

“This work is an example of how federal agencies can work with private researchers to reduce preventable adverse drug events,” Dr. John Whyte, FDA’s director of professional affairs & stakeholder engagement, added. “The goal is to identify the patients who are at highest hypoglycemic risk, so that health care providers can focus their attention on the specific needs of these patients and reduce preventable hypoglycemia harm.”

See the best minds in medtech live at DeviceTalks Boston on Oct. 2. 

Filed Under: Diabetes, Drug-Device Combinations, Featured, Food & Drug Administration (FDA), Pharmaceuticals, Research & Development Tagged With: kaiserpermanente

IN CASE YOU MISSED IT

  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care
  • Insulet up on Q2 sales beat, raised full-year guidance
  • Aptar acquires Orbital dry powder inhaler license
  • Tandem sinks on Q2 misses, slashed sales guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS